138 related articles for article (PubMed ID: 6262541)
1. delta 9-tetrahydrocannabinol in clinical oncology.
Poster DS; Penta JS; Bruno S; Macdonald JS
JAMA; 1981 May 22-29; 245(20):2047-51. PubMed ID: 6262541
[TBL] [Abstract][Full Text] [Related]
2. delta 9-Tetrahydrocannabinol for refractory vomiting induced by cancer chemotherapy.
Lucas VS; Laszlo J
JAMA; 1980 Mar; 243(12):1241-3. PubMed ID: 6244418
[TBL] [Abstract][Full Text] [Related]
3. Antiemetic efficacy of levonantradol compared to delta-9-tetrahydrocannabinol for chemotherapy-induced nausea and vomiting.
Citron ML; Herman TS; Vreeland F; Krasnow SH; Fossieck BE; Harwood S; Franklin R; Cohen MH
Cancer Treat Rep; 1985 Jan; 69(1):109-12. PubMed ID: 2981616
[TBL] [Abstract][Full Text] [Related]
4. Comparative trial of the antiemetic effects of THC and haloperidol.
Neidhart JA; Gagen MM; Wilson HE; Young DC
J Clin Pharmacol; 1981; 21(S1):38S-42S. PubMed ID: 6271838
[TBL] [Abstract][Full Text] [Related]
5. Is THC an effective antiemetic for cancer patients? Opinion 1.
Frytak S
CA Cancer J Clin; 1980; 30(5):278-82. PubMed ID: 6250681
[No Abstract] [Full Text] [Related]
6. Is THC an effective antiemetic for cancer patients? Opinion 2.
Sallan SE; Cronin CM
CA Cancer J Clin; 1980; 30(5):283-5. PubMed ID: 6250682
[No Abstract] [Full Text] [Related]
7. Antiemetic effect of delta 9-tetrahydrocannabinol in chemotherapy-associated nausea and emesis as compared to placebo and compazine.
Orr LE; McKernan JF
J Clin Pharmacol; 1981; 21(S1):76S-80S. PubMed ID: 6271846
[TBL] [Abstract][Full Text] [Related]
8. Amelioration of cancer chemotherapy-induced nausea and vomiting by delta-9-tetrahydrocannabinol.
Ekert H; Waters KD; Jurk IH; Mobilia J; Loughnan P
Med J Aust; 1979 Dec; 2(12):657-9. PubMed ID: 231736
[TBL] [Abstract][Full Text] [Related]
9. delta 9-Tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A pilot study.
Sweet DL; Miller NJ; Weddington W; Senay E; Sushelsky L
J Clin Pharmacol; 1981; 21(S1):70S-75S. PubMed ID: 6271845
[TBL] [Abstract][Full Text] [Related]
10. Intravenous Delta-9-Tetrahydrocannabinol to Prevent Postoperative Nausea and Vomiting: A Randomized Controlled Trial.
Kleine-Brueggeney M; Greif R; Brenneisen R; Urwyler N; Stueber F; Theiler LG
Anesth Analg; 2015 Nov; 121(5):1157-64. PubMed ID: 26426861
[TBL] [Abstract][Full Text] [Related]
11. Stress inoculation training in the control of THC toxicities.
Roffman RA
Int J Addict; 1986 Aug; 21(8):883-96. PubMed ID: 3021638
[TBL] [Abstract][Full Text] [Related]
12. Antiemetics in patients receiving chemotherapy for cancer: a randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine.
Sallan SE; Cronin C; Zelen M; Zinberg NE
N Engl J Med; 1980 Jan; 302(3):135-8. PubMed ID: 6985702
[TBL] [Abstract][Full Text] [Related]
13. A prospective evaluation of delta-9-tetrahydrocannabinol as an antiemetic in patients receiving adriamycin and cytoxan chemotherapy.
Chang AE; Shiling DJ; Stillman RC; Goldberg NH; Seipp CA; Barofsky I; Rosenberg SA
Cancer; 1981 Apr; 47(7):1746-51. PubMed ID: 6261926
[TBL] [Abstract][Full Text] [Related]
14. delta 9-Tetrahydrocannabinol and therapeutic research legislation for cancer patients.
Treffert DA; Joranson DE
JAMA; 1983 Mar; 249(11):1469-72. PubMed ID: 6298477
[TBL] [Abstract][Full Text] [Related]
15. Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placebo.
Frytak S; Moertel CG; O'Fallon JR; Rubin J; Creagan ET; O'Connell MJ; Schutt AJ; Schwartau NW
Ann Intern Med; 1979 Dec; 91(6):825-30. PubMed ID: 517882
[TBL] [Abstract][Full Text] [Related]
16. Delta-9-tetrahydrocannabinol in cancer chemotherapy: research problems and issues.
Carey MP; Burish TG; Brenner DE
Ann Intern Med; 1983 Jul; 99(1):106-14. PubMed ID: 6305249
[TBL] [Abstract][Full Text] [Related]
17. Cannabis and cancer chemotherapy: a comparison of oral delta-9-THC and prochlorperazine.
Ungerleider JT; Andrysiak T; Fairbanks L; Goodnight J; Sarna G; Jamison K
Cancer; 1982 Aug; 50(4):636-45. PubMed ID: 6284334
[TBL] [Abstract][Full Text] [Related]
18. Antiemetic effect of tetrahydrocannabinol. Compared with placebo and prochlorperazine in chemotherapy-associated nausea and emesis.
Orr LE; McKernan JF; Bloome B
Arch Intern Med; 1980 Nov; 140(11):1431-3. PubMed ID: 6254456
[TBL] [Abstract][Full Text] [Related]
19. Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy.
Sallan SE; Zinberg NE; Frei E
N Engl J Med; 1975 Oct; 293(16):795-7. PubMed ID: 1099449
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of tetrahydrocannabinol in patients refractory to standard antiemetic therapy.
McCabe M; Smith FP; Macdonald JS; Woolley PV; Goldberg D; Schein PS
Invest New Drugs; 1988 Sep; 6(3):243-6. PubMed ID: 2847994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
